MR关节造影表现对盂肱关节皮质类固醇注射后短期疼痛缓解的预测价值
本研究前瞻性纳入212例行透视引导下盂肱关节皮质类固醇注射的患者,所有患者在注射前3个月内接受肩关节MR关节造影,并随访1个月评估疼痛数字评分变化。结果显示71%患者在1周、74%患者在1个月时达到临床相关改善(NRS降低≥2分);MR关节造影上粘连性关节囊炎征象及完整盂唇是1个月时更好预后的独立预测因子。
要点
- 盂肱关节皮质类固醇注射后1个月,74%患者疼痛达到临床相关改善(NRS降低≥2分)。
- MR关节造影显示粘连性关节囊炎征象者,1个月NRS降低中位数4分,无此征象者为3分(p=0.007)。
- MR关节造影显示完整盂唇者,1个月NRS降低中位数4分,盂唇不完整者为2分(p=0.003)。
核心结论
- 盂肱关节皮质类固醇注射止痛成功率高,74%患者1个月时报告临床相关改善;MR关节造影上的粘连性关节囊炎征象和完整盂唇是更好预后的独立预测因子。
研究设计与样本
- 前瞻性纳入212例(平均年龄51.4岁,范围15-90岁)接受透视引导下盂肱关节皮质类固醇注射的患者;所有患者在注射前3个月内接受肩关节MR关节造影,并返回问卷用11点数字评分量表(NRS)评估肩痛,随访1个月;MR关节造影图像回顾性评估肩袖、肱二头肌长头腱、盂肱骨、软骨、盂唇异常以及滑膜炎、滑囊炎和粘连性关节囊炎征象;采用Mann-Whitney U检验和Kruskal-Wallis检验进行单因素分析,多因素分析采用多元线性回归。
关键影像表现/征象
- MR关节造影评估内容包括肩袖、肱二头肌长头腱、盂肱骨、软骨、盂唇异常以及滑膜炎、滑囊炎和粘连性关节囊炎征象。
- 粘连性关节囊炎征象和完整盂唇与1个月时更高的NRS降低相关。
诊断标准与关键数值
- 疼痛缓解≥2分被认为代表临床相关改善,1周时71%患者达到,1个月时74%患者达到。
- 有粘连性关节囊炎征象者1个月NRS降低中位数4分 vs 无此征象者3分(p=0.007)。
- 完整盂唇者1个月NRS降低中位数4分 vs 盂唇不完整者2分(p=0.003)。
- 多因素分析:粘连性关节囊炎征象beta=0.176,p=0.039;完整盂唇beta=0.212,p=0.001。
临床应用与阅片要点
- 作者结论认为,MR关节造影上的粘连性关节囊炎征象和完整盂唇是盂肱关节皮质类固醇注射后1个月更好疼痛缓解的独立预测因子。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study was conducted in order to determine the predictive value of MR arthrography findings for pain relief after glenohumeral corticosteroid injection.
METHODS: This study prospectively enrolled 212 patients (mean age 51.4 years; range 15-90) who underwent fluoroscopy-guided glenohumeral corticosteroid injection. All patients received MR arthrography of the shoulder less than 3 months prior to the infiltration and returned questionnaires which assessed patients' shoulder pain using the 11-point numeric rating scale (NRS), covering a 1-month follow-up period. MR arthrograms were retrospectively assessed for abnormalities of the rotator cuff, long biceps tendon, glenohumeral bone, cartilage, and labrum as well as for synovitis, bursitis, and signs of adhesive capsulitis. MR arthrography findings were compared to patients' NRS change using the Mann-Whitney U and Kruskal-Wallis tests for univariate analysis and multiple linear regression for multivariate analysis.
RESULTS: Pain reduction of ≥ 2 points was considered to represent clinically relevant improvement, which was seen in 71% of patients 1 week and in 74% of patients 1 month after glenohumeral injection. Univariate analysis of MR findings showed that signs of adhesive capsulitis and an intact labrum were associated with significantly higher NRS reductions after 1 month in comparison to patients without these findings (median 4 vs. 3, p = 0.007 and 4 vs. 2, p = 0.003, respectively). Multivariate analysis proved both factors to be independent predictors of improved outcome after 1 month (beta = 0.176, p = 0.039 and beta = 0.212, p = 0.001, respectively).
CONCLUSIONS: Glenohumeral corticosteroid injections for pain relief have a high success rate with 74% of patients reporting clinically relevant improvement after 1 month. Signs of adhesive capsulitis and an intact labrum on MR arthrography are independent predictors of a better outcome.
KEY POINTS: • Seventy-four percent of patients report clinically relevant improvement 1 month after glenohumeral corticosteroid injection. • Signs of adhesive capsulitis and an intact labrum on MR arthrography are independent predictors of a high pain level decrease.
引用
- Fritz B, Del Grande F, Sutter R, et al. Value of MR arthrography findings for pain relief after glenohumeral corticosteroid injections in the short term. Eur Radiol. 2019. PMID: 31209618. doi:10.1007/s00330-019-06237-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。